Thilo completed a bachelor’s degree (magna cum laude; 2012) in psychology with minors in chemistry & biology in the USA (UNO), a research master’s (2014) in Neuroscience & Neuropharmacology at the University Bordeaux & Free University Amsterdam (Erasmus Mundus NEURASMUS scholar), and his doctoral research (2022) on viral vector-based gene therapy on the eye on animal and human iPSCs differentiated to retinal organoids at the Leiden University Medical Center (LUMC). Experiencing the roadblocks in bench-to-bedside personalized medicines for ATMPs, after his doctoral work he focused on viral vector process development & technical writing in pharmaceutical manufacturing at NecstGen (2021). There he primarily worked on analytical development, USP (suspension cells), DSP (Äkta systems), and agile project management. Between 2012-2015 he worked as a part-time clean room engineer on (re-)qualification (DQ, IQ, OQ, PQ, airflow & particle measurements) and installation (e.g., filters, walls) at various manufacturing facilities while working for the company bc-technology. He is a member of ISPE and DARQA and wants to actively contribute to the development of bench-to-bedside personalized medicines.